Scrip's Five Must-Know Things: Key ESMO Readouts, Next-Gen ADCs And Mid-Cap Winners

Join us for an audio catch-up on the major events in the global biopharma industry over the past week, as reported by Scrip’s global team, in this podcast version of Five Must-Know Things.

This episode covers insights for the business week ended Oct. 23, 2026. This time—key expectations from ESMO meeting; next-generation antibody-drug conjugates; rising mid-cap stars; GSK's novel hepatitis B launch; and significant private company financings.

Story links here (insights.citeline.com/scrip/podcasts/scrips-fi…).

This and all our other podcasts are available on the Scrip channel on Apple Podcasts (podcasts.apple.com/us/podcast/scrip-podcasts/i…), and Spotify Podcasts (open.spotify.com/show/54Ki1l5bTzuxvrUylwbvO9?s…) and on TuneIn (tunein.com/podcasts/Business--Economics-Podcas…).

Scrip YouTube Podcasts: youtube.com/@scrip-commercial/podcasts (nam04.safelinks.protection.outlook.com/?url=ht…)

Pink Sheet YouTube Podcasts: youtube.com/@pinkSheet-regulatory-n/podcasts (nam04.safelinks.protection.outlook.com/?url=ht…)

Any comments? podcasts@norstella.com